Form 8-K - Current report:
SEC Accession No. 0001493152-21-004211
Filing Date
2021-02-18
Accepted
2021-02-18 08:27:54
Documents
15
Period of Report
2021-02-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 33653
2 ex99-1.htm EX-99.1 10782
3 ex99-2.htm EX-99.2 23080
4 ex99-1_001.jpg GRAPHIC 131279
5 ex99-1_002.jpg GRAPHIC 167290
6 ex99-1_003.jpg GRAPHIC 138201
7 ex99-1_004.jpg GRAPHIC 153081
8 ex99-1_005.jpg GRAPHIC 172616
9 ex99-1_006.jpg GRAPHIC 163798
10 ex99-1_007.jpg GRAPHIC 174404
11 ex99-1_008.jpg GRAPHIC 116803
12 ex99-1_009.jpg GRAPHIC 144477
13 ex99-1_010.jpg GRAPHIC 109460
14 ex99-1_011.jpg GRAPHIC 60953
15 ex99-2_001.jpg GRAPHIC 4100
  Complete submission text file 0001493152-21-004211.txt   2185769
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21990 | Film No.: 21647737
SIC: 2834 Pharmaceutical Preparations